Alkermes Plc
NASDAQ:ALKS

Watchlist Manager
Alkermes Plc Logo
Alkermes Plc
NASDAQ:ALKS
Watchlist
Price: 29.24 USD 0.03% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Alkermes Plc?
Write Note

Wall Street
Price Targets

ALKS Price Targets Summary
Alkermes Plc

Wall Street analysts forecast ALKS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALKS is 35.62 USD with a low forecast of 21.21 USD and a high forecast of 52.5 USD.

Lowest
Price Target
21.21 USD
27% Downside
Average
Price Target
35.62 USD
22% Upside
Highest
Price Target
52.5 USD
80% Upside

ALKS Last Price Targets
Alkermes Plc

The latest public price target was made on Nov 13, 2024 by Vamil Divan from Mizuho Securities , who expects ALKS stock to rise by 37% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Vamil Divan
Mizuho Securities
40 USD
Upside 37%
1 day ago
Nov 13, 2024
Alkermes (ALKS) PT Raised to $40 at Mizuho
StreetInsider
Paul Matteis
Stifel Nicolaus
36 USD
Upside 23%
1 week ago
Nov 4, 2024
Stifel Upgrades Alkermes (ALKS) to Buy
StreetInsider
Paul Matteis
Stifel Nicolaus
25 USD
Downside 15%
3 weeks ago
Oct 24, 2024
Alkermes (ALKS) PT Lowered to $25 at Stifel
StreetInsider
Douglas Tsao
H.C. Wainwright
37 USD
Upside 27%
1 month ago
Oct 14, 2024
H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)
StreetInsider
Akash Tewari
Jefferies
50 USD
Upside 71%
7 months ago
Apr 10, 2024
Alkermes (ALKS) PT Raised to $50 at Jefferies
StreetInsider
Vamil Divan
Mizuho Securities
35 USD
Upside 20%
7 months ago
Apr 9, 2024
Mizuho on Alkermes (ALKS): 'We maintain our Buy rating, believing that ALKS 2680 is underappreciated'
StreetInsider
Akash Tewari
Jefferies
25 USD
Downside 15%
7 months ago
Apr 9, 2024
Alkermes price target raised to $50 at Jefferies after 'excellent' NT2 data
TheFly
Joel Beatty
Robert W. Baird
37 USD
Upside 27%
7 months ago
Mar 18, 2024
Baird Starts Alkermes (ALKS) at Outperform
StreetInsider
Show More Price Targets
Show Less Price Targets
Vamil Divan
Mizuho Securities
Price Target 40 USD
Upside/Downside 37%
View Source
Paul Matteis
Stifel Nicolaus
Price Target 36 USD
Upside/Downside 23%
View Source
Paul Matteis
Stifel Nicolaus
Price Target 25 USD
Upside/Downside 15%
View Source
Douglas Tsao
H.C. Wainwright
Price Target 37 USD
Upside/Downside 27%
View Source
Akash Tewari
Jefferies
Price Target 50 USD
Upside/Downside 71%
View Source
Vamil Divan
Mizuho Securities
Price Target 35 USD
Upside/Downside 20%
View Source
Akash Tewari
Jefferies
Price Target 25 USD
Upside/Downside 15%
View Source
Joel Beatty
Robert W. Baird
Price Target 37 USD
Upside/Downside 27%
View Source
Show More Price Targets
Show Less Price Targets
Alkermes Plc Competitors:
Price Targets
NTLA
Intellia Therapeutics Inc
328% Upside
AVTE
Aerovate Therapeutics Inc
10% Downside
TVTX
Travere Therapeutics Inc
18% Upside
RXRX
Recursion Pharmaceuticals Inc
41% Upside
LTRN
Lantern Pharma Inc.
536% Upside
002007
Hualan Biological Engineering Inc
32% Upside
ELDN
Eledon Pharmaceuticals Inc
234% Upside
2616
CStone Pharmaceuticals
41% Upside

Revenue
Forecast

Revenue Estimate
Alkermes Plc

For the last 8 years the compound annual growth rate for Alkermes Plc's revenue is 13%. The projected CAGR for the next 3 years is -2%.

13%
Past Growth
-2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Alkermes Plc

The compound annual growth rate of Alkermes Plc's operating income for the next 3 years is 3%.

N/A
Past Growth
3%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Alkermes Plc

The compound annual growth rate of Alkermes Plc's net income for the next 3 years is 3%.

N/A
Past Growth
3%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALKS's stock price target?
Price Target
35.62 USD

According to Wall Street analysts, the average 1-year price target for ALKS is 35.62 USD with a low forecast of 21.21 USD and a high forecast of 52.5 USD.

What is Alkermes Plc's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Alkermes Plc's revenue is 13%. The projected CAGR for the next 3 years is -2%.

What is Alkermes Plc's Operating Income forecast?
Projected CAGR
3%

The compound annual growth rate of Alkermes Plc's operating income for the next 3 years is 3%.

What is Alkermes Plc's Net Income forecast?
Projected CAGR
3%

The compound annual growth rate of Alkermes Plc's net income for the next 3 years is 3%.

Back to Top